Gaurav Paul

766 citations
6 papers · 569 indexed · 1 hit paper · h-index 4
Topics
Cholinesterase and Neurodegenerative Diseases (2 papers)Advanced Glycation End Products research (2 papers)Alzheimer's disease research and treatments (2 papers)
Journals
Expert Opinion on Investigational DrugsSouth Asian Journal of Business and Management CasesIndian Journal of Clinical and Experimental Ophthalmology
Partner nations
United StatesIndia

In The Last Decade

Gaurav Paul

5 papers receiving 560 citations

Hit Papers

Why do trials for Alzheimer’s disease drugs keep failing?...20172026202020232017100200300400

Peers

Gaurav Paul
Comparison fields: 5 of 89
  • Physiology 284
  • Molecular Biology 191
  • Pharmacology 114
  • Neurology 96
  • Psychiatry and Mental health 85
Replace Minna A. Korolainen with:
Minna A. Korolainen Finland
Babak Sabermarouf Iran
Mar Pacheco‐Herrero Dominican Republic
Michał Prendecki Poland
Hirra A. Arain United States
Ravi Rajmohan United States
Patrícia Regina Manzine Brazil
Gaurav Paul relative to Minna A. Korolainen Finland Minna A. Korolainen's profile →
Citations per field
00.5×
Minna A. Korolainen · 1×
Citations per year

Countries citing papers authored by Gaurav Paul

Since Specialization
Citations

This map shows the geographic impact of Gaurav Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaurav Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaurav Paul more than expected).

Fields of papers citing papers by Gaurav Paul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaurav Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaurav Paul. The network helps show where Gaurav Paul may publish in the future.

Co-authorship network of co-authors of Gaurav Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Gaurav Paul. A scholar is included among the top collaborators of Gaurav Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaurav Paul. Gaurav Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 4
2 3
3
Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015breakdown →
444
4 65
5 53
6
The Genetics of Ovarian Failure
0

About Gaurav Paul

Gaurav Paul is a scholar working on Clinical Biochemistry, Computational Theory and Mathematics and Pharmacology, having authored 6 papers that have together received 569 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (2 papers), Advanced Glycation End Products research (2 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Biological Psychiatry (36 citations), Neurology (96 citations) and Physiology (284 citations). Gaurav Paul has collaborated with scholars based in United States and India. Frequent co-authors include Marwan N. Sabbagh, Robert Jackson, Dev Mehta, Jiong Shi, Lih Fen Lue, Douglas G. Walker and Neeraj Pandey. Their work appears in journals such as Expert Opinion on Investigational Drugs, South Asian Journal of Business and Management Cases and Indian Journal of Clinical and Experimental Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026